Ambani is a businesswoman, educationist, philanthropist and a strong proponent of sports.
Its primary business activities are to manage conduct of: The patent for this discovery is already filed by Novalead Pharma Inc. To manage preclinical studies for other candidates in discovery pipeline of the parent company in Innovation in cipla. The actual biological validation will be outsourced to third party research labs preferably within MA.
Chellaram Chairman of the Chellaram Group, Lal Chellaram is a highly respected entrepreneur having developed a wide range of international businesses including Shipping, Property investment, Consumer manufacturing and Electronics distribution.
He established the Chellaram Foundation which provides poverty relief, educational support and medical care to the poor and dispossessed. Visalakshi Chandramouli has over 16 years of experience in the Indian healthcare financing industry and the pharmaceutical industry.
At Tata Capital Private Equity, she leads the healthcare team and drives the fund raising and investment management activities.
Visalakshi is a Chemical Technologist from U. T and holds a M. Although working with some of the most respected names in the UK financial industry his particular focus was on understanding and helping in the development of entrepreneurial businesses.
He joined the Chellaram Group in where he has been instrumental in developing investment opportunities and in raising and deploying finance.
Developing new markets, designing and implementing business strategies and leading market linked product strategies are some of the key areas of his contribution. With business development experience in multiple geographies like the USA, Europe, Latin America, Africa and Asia, Supreet brings with him significant learning for building an efficient and result oriented organization.
Atul has over 22 years of experience in technology and operations management.
Previously he has worked with large international organizations like Fujitsu and Indian software enterprises like ZenSar. At NovaLead, Atul has been a significant contributor in the evolution of its technology platform and in management of the Galnobax clinical trial.
He has been proponent of drug repurposing for past 12 years. He did his post doctoral studies at Nagoya University, Japan. He has been faculty at Department of Chemistry, University of Pune for about 7 years.
Currently he is focussing on development of Galnobax as well as new pipeline products. He has 52 research publications and 5 patents to his credit. Com Degree from Pune University. She has more than 22 years of experience in the profession. From his current position as VP, Technology he is in charge of the various activities related technology development and technology based services.Pharmaceutical companies have contributed to people’s improved health and prolonged life, generally speaking.
Research and development of drugs that are brought to market can be costly and there are strict regulations and requirements that companies must follow in most countries.
Project Report on Pharma Industry, MBA/BBA Marketing Project Report on Pharmaceutical Companies, MBA Project on Dealers and Consumer Survey, Comparative Study of Marketing of Different Products of Various Pharmaceutical Companies Project Report.
Prof Renuka Vithal. Honorary Professor of Mathematics Education in the School of Education,University of the Witwatersrand.
NovaLead is a drug discovery research company focused on discovering new indications for generic drugs. Enabled by proprietary technology platform, NovaLead's drug repositioning approach is targeted at finding new biological targets for generic drugs, thereby discovering new indication possibilities.
Dr. K. Bangarurajan did his Degree in Pharmacy from Madras Medical College and M. Pharmacy from Banaras Hindu University, Varanasi in the Year and was awarded Ph.D. by Tamil Nadu Dr. MGR Medical University in the Year Cipla Limited - Offering Formulation Development, Research & Innovation in Midc, Daund, Maharashtra.
Read about company and get contact details and address.